Promising Dual Immunotherapy for Anaplastic Thy...

By Rene Pretorius

January 10, 2025

We review the results from the phase 2 nonrandomized clinical trial on the clinical activity of dual immune checkpoint inhibition in aggressive thyroid cancer. The purpose of the study was to...
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
Heplisav-B: A Superior Hepatitis B Vaccine for Individuals with HIV
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Improving Cervical Cancer Screening: HPV Self-Collection Tests
Overview of NICE’s Elranatamab Managed Access Agreement
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
FDA Approves Inavolisib Breast Cancer Treatment
Enhancing Mental Health Care for Youth: A Critical Need